Skip to main content

Table 4 The residual liver volume before and after DEB-TACE and cTACE

From: Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients

No.

DEB-TACE group (N = 15)

 

cTACE group (N = 8)

 

Before DEB-TACE

After DEB-TACE

Increase rate (%)

p-value

Before cTACE

After cTACE

Increase rate (%)

p-value

1

1182.0

1064.0

−10.0

 

1157

1201

3.8

 

2

1006.0

1083.0

7.7

 

935

1112

18.9

 

3

1266.0

1407.0

11.1

 

1104

1121

1.5

 

4

1021.8

972.8

−4.8

0.007

1211

1115

−7.9

0.339

5

705.0

832.0

18.0

 

854

864

1.2

 

6

1514.0

1659.0

9.6

 

1125

1114

−0.97

 

7

796.8

706.0

−11.4

 

801

856

6.8

 

8

784.0

1169.0

49.1

 

1184

1209

2.1

 

9

1547.0

1740.0

12.5

     

10

1266.0

1358.0

7.3

     

11

1371.0

1371.0

0.0

     

12

1127.0

1347.0

19.5

     

13

944.0

1066.0

12.9

     

14

909.0

1100.0

21.0

     

15

554.0

713.0

28.7

     

Mean

1066.2

1180.3

11.4

 

1046.4

1074.0

2.6

 
  1. Comparison was determined by paired-sample t-test